Overall Score

Valuation

Trading at a low sales multiple (EV/Sales TTM 0.66, P/S 0.50) and near book value (P/B 0.99), which supports a discounted valuation case.

Negative earnings and free cash flow metrics (P/E TTM -6.73, FCF yield -6.47%) limit the quality of the valuation support.

Financial Health

Liquidity remains solid with a current ratio of 2.84 and quick ratio of 1.67, indicating adequate short-term coverage.

Leverage is manageable but not trivial, with net debt/EBITDA at 1.22 and debt-to-equity at 0.55.

Cash generation is weak relative to obligations, as operating cash flow coverage is low and free cash flow remains negative.

Profitability

Gross margin is strong at 69.6%, showing the core product economics remain healthy.

Operating performance is still negative, with EBIT margin at -4.6% and net margin at -7.4%.

Returns remain below zero across ROA, ROE, and ROIC, indicating the business is not yet earning its cost of capital.

Growth

Revenue productivity appears stable, with revenue per share at 20.37 and asset turnover at 0.95.

However, the company is still not translating sales into positive bottom-line growth, as margins remain negative.

Momentum

The stock appears inexpensive on trailing multiples, but the market is still discounting weak profitability and cash flow.

No recent news catalyst is present to improve near-term sentiment.